ArticleJournal of experimental & clinical cancer research : CR2017

Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2.

Wei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.